Recent Updates
Recently added Catalysts
DBVT

DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company

Key Takeaway: Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of shares Tota

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+12%
120-day peak, hindsight
Typical move
14%
average across 3 past catalysts
Cash runway
~9 mo
Medium dilution risk
Lead asset
DBV712
Phase 3 · Peanut Allergy

Full Press Release Details

Monthly information regarding the total number of voting rights and
total number of shares of the Company
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
Date Total number of shares Total number of voting rights
12/31/2018 30,157,777 Total gross of voting rights: 30,157,777
Total net* of voting rights: 30,116,618
* Total net = total number of voting rights attached to shares - shares without voting rights
Last updated: Jan 11, 2019